Dana Rollison PhD Email Address

Member, Board of Directors

Moffitt Cancer Center are contribute to the prevention and cure of cancer.

Dr. Dana Rollison is the Vice President, Chief Data Officer (VP, CDO) and Associate Center Director (ACD) of Data Science at Moffitt Cancer Center in Tampa, FL. Dr. Rollison joined the research faculty at Moffitt Cancer Center in 2004, after earning her undergraduate degree in biology with honors from the University of Miami and completing her master's, doctoral and postdoctoral training in cancer epidemiology at the Johns Hopkins University. Currently a Senior Member, her research focuses on the application of data science techniques to unravel cancer etiology, enhance cancer surveillance, and advance care delivery. As VP, CDO and ACD of Data Science, Dr. Rollison drives innovation in three key areas: 1) Scientific leadership of the Division of Quantitative Science within the Moffitt Research Institute, including the academic departments of Biostatistics and Bioinformatics, Integrated Mathematical Oncology, and Machine Learning, and multiple data-related shared resources; 2) Strategic visioning for Moffitt’s Cancer Analytics Platform (MCAP), the center’s cloud-based enterprise wide data warehouse and analytics hub, and executive leadership of Moffitt’s Enterprise Wide Analytics Strategy (EWAS) and associated data governance committees, bringing together clinical and research faculty and operational leaders in support of translational research, accountable care analytics, and the practice of personalized medicine. 3) Transformational leadership of Health Data Services, including four departments dedicated to providing access to high-quality patient data and associated insights: Cancer Registry, Data Quality & Business Intelligence, Health Informatics, and Advanced Analytics. Leveraging her dual role as CDO and ACD, Dr. Rollison seeks to orchestrate and optimize Moffitt’s extensive data assets across clinical, research and operational areas of the organization, thus accelerating scientific discovery and ultimately improving patient outcomes across the cancer continuum. Dr. Rollison is an active advisor to several organizations through her membership on the Cancer Advisory Informatics Group for the North American Association of Central Cancer Registries (NAACCR), the external advisory boards (EABs) for the University of Kentucky Markey Cancer Center and Sidney Kimmel Cancer Center at Jefferson Health, and the Board of Directors for NanoString Technologies, Inc.